The content on this page is designed for Canada (FR). Check courses designed for Canada (EN)

This course has expired. View available courses.

Cardiovasculaire

Utilisation des bêtabloquants dans le traitement de l’hypertension : Mythes, idées fausses et faits – Mainpro+

DURATION

PROFESSION

Physician

# OF CREDITS

1

ACCREDITATION

Mainpro+

EXPIRY DATE

2015-06-04

Learning objectives

  1. De mettre en application les directives du Programme éducatif canadien sur l'hypertension (PECH) dans la prise en charge de l'hypertension légère à modérée.
  2. Reconnaître et énoncer les mythes associés à l'utilisation des bêtabloquants dans la prise en charge de l'hypertension.
  3. Décrire le rôle des bêtabloquants dans la prise en charge de l'hypertension.
  4. Différencier les bêtabloquants indiqués pour la prise en charge de l'hypertension au Canada.
Cost of course:  
Free
# of credits: 1
Duration:

FAQs & HELP

MDBriefCase Group specializes in accredited, online continuing professional development (CPD) programs, custom tailored for specific international markets and available on a convenient online platform.

All content is developed by leading specialists and peer-reviewed by experts at respected institutions, which keeps more than 280,000 global healthcare professionals at the forefront of the latest evidence and protocols worldwide.

The vast majority of our programs are accredited by one or more respected institutions. We do provide unaccredited content to ensure that healthcare professionals have access to relevant practical resources in addition to accredited learning.

Specific accrediting information (including the accrediting body, along with the type and number of credits) can be found on the “Main” page and/or “Accreditation” page of each program. In order to qualify for accreditation and obtain your certificate, you must successfully complete the requirements listed on the “Accreditation” or “CME Information” pages available in each program.

MDBriefCase Group works with various institutions to provide peer-reviewed, up-to-date accredited content. Our programs and resources are provided via collaboration between medical writers, faculty members, associations, universities and other relevant organizations. The content you were recommended is likely valued by your society or association and is conveniently provided to you free of charge on an MDBriefCase Group platform.

Specific accrediting information (including the accrediting body, along with the type and number of credits) can be found on the “Main” page and/or “Accreditation” page of each program. In order to qualify for accreditation and obtain your certificate, you must successfully complete the requirements listed on the “Accreditation” or “CME Information” pages available in each program.

No, registration with MDBriefCase is free!

To access your profile, visit My Profile. If you would like to update the information here don’t forget to hit the ‘save’ button when you are finished. Your profile is where you can control what email communications you receive.

If you have forgotten your password, you can reset your password. To access this page from the Login page, click Forgot password. Enter the email address you registered with and you will receive an email with a link to reset your password.

Please note: if you submitted multiple password resets, only the link on the most recent email is valid.

You can unsubscribe from MDBriefCase Group emails by clicking the unsubscribe button located at the bottom of each of our emails.

Utilisation des bêtabloquants dans le traitement de l’hypertension : Mythes, idées fausses et faits – Mainpro+

Duration

Physician

Profession

1

# of credits

Learning Objectives

  1. De mettre en application les directives du Programme éducatif canadien sur l’hypertension (PECH) dans la prise en charge de l’hypertension légère à modérée.
  2. Reconnaître et énoncer les mythes associés à l’utilisation des bêtabloquants dans la prise en charge de l’hypertension.
  3. Décrire le rôle des bêtabloquants dans la prise en charge de l’hypertension.
  4. Différencier les bêtabloquants indiqués pour la prise en charge de l’hypertension au Canada.

Mainpro+

ACCREDITATION

Cardiovasculaire

Learning Category

General

Topic

0

Price

2015-06-04

Expiry Date

CAN-fr

Region/Language

Course Description

Faculty

ACF Faculty

Accreditation

Unaccredited